Skip to main content

Table 2 The mean change scores (post-treatment and follow-up scores adjusted for baselinea) for the clinical outcome measures, including the number of participants (N), means, and standard deviations (SD) for the antidepressant and no antidepressant groups, and the estimated between-groups effect size (Cohen’s d with 95% confidence intervals)

From: A preliminary exploration of the effect of concurrent antidepressant medication on responses to high-frequency repetitive transcranial magnetic stimulation (rTMS) in severe, enduring anorexia nervosa

Measure Antidepressants No antidepressants Between- subject d (95% CI)
N Mean SD N Mean SD
Post-treatment (adjusted for baselinea)
 BMI 16 0.03 0.72 10 0.16 0.36 0.22 (− 0.58 to 1.01)
 EDE-Q Global 16 − 0.34 0.68 10 − 0.09 0.56 0.40 (−0.41 to 1.19)
 EDE-Q Restraint 16 −0.18 0.73 10 0.14 0.67 0.45 (−0.36 to 1.24)
 EDE-Q Eating Concern 16 −0.43 0.83 10 −0.12 0.84 0.37 (−0.43 to 1.16)
 EDE-Q Shape Concern 16 −0.45 0.74 10 −0.10 1.11 0.38 (−0.42 to 1.18)
 EDE-Q Weight Concern 16 −0.33 0.83 10 −0.30 0.94 0.03 (−0.76 to 0.82)
 DASS-21 Total 16 −9.00 22.14 10 −16.2 19.31 −0.34 (−1.13 to 0.46)
 DASS-21 Depression 16 −1.25 8.61 10 −4.80 8.34 −0.42 (−1.21 to 0.39)
 DASS-21 Anxiety 16 −3.63 8.86 10 −4.20 4.76 −0.08 (− 0.87 to 0.72)
Follow-up (adjusted for baselinea)
 BMI 15 0.27 1.17 10 0.06 0.89 −0.20 (−1.00 to 0.91)
 EDE-Q Global 15 −0.88 0.85 10 −0.03 0.62 1.10 (0.23 to 1.96)
 EDE-Q Restraint 15 −0.75 1.29 10 0.18 0.68 0.85 (0.001 to 1.67)
 EDE-Q Eating Concern 15 −0.67 1.06 10 0.06 0.95 0.71 (−0.12 to 1.53)
 EDE-Q Shape Concern 15 −1.06 0.83 10 −0.09 0.83 1.17 (0.29 to 2.03)
 EDE-Q Weight Concern 15 −1.04 1.01 10 −0.28 0.67 0.85 (0.006 to 1.68)
 DASS-21 Total 15 −17.33 23.80 10 −14.4 18.40 0.13 (−0.69 to 0.93)
 DASS-21 Depression 15 −8.13 10.43 10 −4.20 8.24 0.41 (−0.41 to 1.21)
 DASS-21 Anxiety 15 −4.40 7.57 10 −3.00 7.13 0.19 (−0.62 to 0.99)
  1. Abbreviations: N Number, SD Standard deviation, CI Confidence intervals, BMI Body mass index, EDE-Q Eating Disorder Examination – Questionnaire, DASS-21 Depression Anxiety and Stress Scales – Version 21
  2. aPost-treatment/follow-up scores minus baseline scores. Bold font signifies that the CI do not include 0
\